Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Contrasting effects of ATP and adenosine on capsaicin challenge in asthmatic patients.

Basoglu OK, Pelleg A, Kharitonov SA, Barnes PJ.

Pulm Pharmacol Ther. 2017 Aug;45:13-18. doi: 10.1016/j.pupt.2017.04.004. Epub 2017 Apr 6.

2.

Effects of Aerosolized Adenosine 5'-Triphosphate in Smokers and Patients With COPD.

Basoglu OK, Barnes PJ, Kharitonov SA, Pelleg A.

Chest. 2015 Aug;148(2):430-435. doi: 10.1378/chest.14-2285.

PMID:
25590209
3.

A novel approach to partition central and peripheral airway nitric oxide.

Paredi P, Kharitonov SA, Meah S, Barnes PJ, Usmani OS.

Chest. 2014 Jan;145(1):113-119. doi: 10.1378/chest.13-0843.

PMID:
23989961
4.

Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry.

Bikov A, Paschalaki K, Logan-Sinclair R, Horváth I, Kharitonov SA, Barnes PJ, Usmani OS, Paredi P.

BMC Pulm Med. 2013 Jul 9;13:43. doi: 10.1186/1471-2466-13-43.

5.

Comparison of Symbicort® versus Pulmicort® on steroid pharmacodynamic markers in asthma patients.

Essilfie-Quaye S, Ito K, Ito M, Kharitonov SA, Barnes PJ.

Respir Med. 2011 Dec;105(12):1784-9. doi: 10.1016/j.rmed.2011.08.020. Epub 2011 Sep 7.

6.

Assessment of reproducibility of exhaled hydrogen peroxide concentration and the effect of breathing pattern in healthy subjects.

Gajdocsi R, Bikov A, Antus B, Horvath I, Barnes PJ, Kharitonov SA.

J Aerosol Med Pulm Drug Deliv. 2011 Dec;24(6):271-5. doi: 10.1089/jamp.2011.0875. Epub 2011 Jun 20.

PMID:
21689021
7.

Inflammatory markers: exhaled nitric oxide and carbon monoxide during the ovarian cycle.

Antczak A, Ciebiada M, Kharitonov SA, Gorski P, Barnes PJ.

Inflammation. 2012 Apr;35(2):554-9. doi: 10.1007/s10753-011-9345-1.

8.

Osteoprotegerin in sputum is a potential biomarker in COPD.

To M, Ito K, Ausin PM, Kharitonov SA, Barnes PJ.

Chest. 2011 Jul;140(1):76-83. doi: 10.1378/chest.10-1608. Epub 2010 Dec 2.

PMID:
21127170
9.

Nitric oxide synthase isoenzyme expression and activity in peripheral lung tissue of patients with chronic obstructive pulmonary disease.

Brindicci C, Kharitonov SA, Ito M, Elliott MW, Hogg JC, Barnes PJ, Ito K.

Am J Respir Crit Care Med. 2010 Jan 1;181(1):21-30. doi: 10.1164/rccm.200904-0493OC. Epub 2009 Sep 24.

10.

The acute effect of swimming on airway inflammation in adolescent elite swimmers.

Pedersen L, Lund TK, Mølgaard E, Kharitonov SA, Barnes PJ, Backer V.

J Allergy Clin Immunol. 2009 Feb;123(2):502-4. doi: 10.1016/j.jaci.2008.11.039. No abstract available.

PMID:
19203664
11.

Effects of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on nitric oxide production and its metabolites in healthy control subjects, healthy smokers, and COPD patients.

Brindicci C, Ito K, Torre O, Barnes PJ, Kharitonov SA.

Chest. 2009 Feb;135(2):353-367. doi: 10.1378/chest.08-0964. Epub 2008 Aug 21.

PMID:
18719059
12.

Feasibility and interpretation of FE(NO) measurements in asthma patients in general practice.

Torre O, Olivieri D, Barnes PJ, Kharitonov SA.

Respir Med. 2008 Oct;102(10):1417-24. doi: 10.1016/j.rmed.2008.04.004. Epub 2008 Jul 11.

13.

Airway responsiveness and inflammation in adolescent elite swimmers.

Pedersen L, Lund TK, Barnes PJ, Kharitonov SA, Backer V.

J Allergy Clin Immunol. 2008 Aug;122(2):322-7, 327.e1. doi: 10.1016/j.jaci.2008.04.041. Epub 2008 Jun 12.

PMID:
18554704
14.

Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations.

Kharitonov SA, Sjöbring U.

Contrib Microbiol. 2007;14:83-100. Review.

PMID:
17684334
15.

Loss of control of asthma following inhaled corticosteroid withdrawal is associated with increased sputum interleukin-8 and neutrophils.

Maneechotesuwan K, Essilfie-Quaye S, Kharitonov SA, Adcock IM, Barnes PJ.

Chest. 2007 Jul;132(1):98-105. Epub 2007 Jun 5.

PMID:
17550933
16.

Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers.

Brindicci C, Ito K, Barnes PJ, Kharitonov SA.

Chest. 2007 Aug;132(2):581-8. Epub 2007 Jun 5.

PMID:
17550932
17.

Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity.

Brindicci C, Ito K, Barnes PJ, Kharitonov SA.

Chest. 2007 May;131(5):1353-62.

PMID:
17494785
18.

Normal bronchial blood flow in COPD is unaffected by inhaled corticosteroids and correlates with exhaled nitric oxide.

Paredi P, Ward S, Cramer D, Barnes PJ, Kharitonov SA.

Chest. 2007 Apr;131(4):1075-81.

PMID:
17426212
19.

Exhaled biomarkers.

Kharitonov SA, Barnes PJ.

Chest. 2006 Nov;130(5):1541-6. Review.

PMID:
17099035
20.

Real-time measurement of particulate matter deposition in the lung.

Invernizzi G, Boffi R, Ruprecht AA, Barnes PJ, Kharitonov SA, Paredi P.

Biomarkers. 2006 May-Jun;11(3):221-32.

PMID:
16760131
21.

Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma.

Paraskakis E, Brindicci C, Fleming L, Krol R, Kharitonov SA, Wilson NM, Barnes PJ, Bush A.

Am J Respir Crit Care Med. 2006 Aug 1;174(3):260-7. Epub 2006 Apr 20.

PMID:
16627868
22.

Exhaled breath condensate cysteinyl leukotrienes and airway remodeling in childhood asthma: a pilot study.

Lex C, Zacharasiewicz A, Payne DN, Wilson NM, Nicholson AG, Kharitonov SA, Barnes PJ, Bush A.

Respir Res. 2006 Apr 7;7:63.

23.

Pulmonary biomarkers in chronic obstructive pulmonary disease.

Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, Saetta M.

Am J Respir Crit Care Med. 2006 Jul 1;174(1):6-14. Epub 2006 Mar 23. Review.

PMID:
16556692
24.

Effect of montelukast on exhaled leukotrienes and quality of life in asthmatic patients.

Biernacki WA, Kharitonov SA, Biernacka HM, Barnes PJ.

Chest. 2005 Oct;128(4):1958-63.

PMID:
16236841
25.

Formoterol attenuates neutrophilic airway inflammation in asthma.

Maneechotesuwan K, Essilfie-Quaye S, Meah S, Kelly C, Kharitonov SA, Adcock IM, Barnes PJ.

Chest. 2005 Oct;128(4):1936-42.

PMID:
16236838
26.

Effects of aerosolized adenosine 5'-triphosphate vs adenosine 5'-monophosphate on dyspnea and airway caliber in healthy nonsmokers and patients with asthma.

Basoglu OK, Pelleg A, Essilfie-Quaye S, Brindicci C, Barnes PJ, Kharitonov SA.

Chest. 2005 Oct;128(4):1905-9.

PMID:
16236834
27.

Influence of different therapeutic strategies on exhaled NO and lung inflammation in asthma and COPD.

Kharitonov SA.

Vascul Pharmacol. 2005 Dec;43(6):371-8. Epub 2005 Sep 28. Review.

PMID:
16198155
28.

Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD.

Montuschi P, Macagno F, Parente P, Valente S, Lauriola L, Ciappi G, Kharitonov SA, Barnes PJ, Ciabattoni G.

Thorax. 2005 Oct;60(10):827-33.

29.
30.

Repeatability of standardised nasal nitric oxide measurements in healthy and asthmatic adults and children.

Kharitonov SA, Walker L, Barnes PJ.

Respir Med. 2005 Sep;99(9):1105-14. Epub 2005 Mar 17.

31.

Exhaled 8-isoprostane in childhood asthma.

Shahid SK, Kharitonov SA, Wilson NM, Bush A, Barnes PJ.

Respir Res. 2005 Jul 21;6:79.

32.

Exhaled nitric oxide from lung periphery is increased in COPD.

Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA.

Eur Respir J. 2005 Jul;26(1):52-9.

33.

Inflammatory response to sputum induction measured by exhaled markers.

Antczak A, Kharitonov SA, Montuschi P, Gorski P, Barnes PJ.

Respiration. 2005 Nov-Dec;72(6):594-9. Epub 2005 Jul 1.

PMID:
15988171
34.

NOS:molecular mechanisms, clinical aspects, therapeutic and monitoring approaches.

Kharitonov SA.

Curr Drug Targets Inflamm Allergy. 2005 Apr;4(2):141-9. Review.

PMID:
15853734
35.

Correlation of exhaled breath temperature with bronchial blood flow in asthma.

Paredi P, Kharitonov SA, Barnes PJ.

Respir Res. 2005 Feb 10;6:15.

36.

Supplementary oxygen in healthy subjects and those with COPD increases oxidative stress and airway inflammation.

Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ.

Thorax. 2004 Dec;59(12):1016-9.

37.

Exhaled nitric oxide and hydrogen peroxide concentrations in asthmatic smokers.

Horváth I, Donnelly LE, Kiss A, Balint B, Kharitonov SA, Barnes PJ.

Respiration. 2004 Sep-Oct;71(5):463-8.

PMID:
15467323
38.

Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma.

Bucchioni E, Csoma Z, Allegra L, Chung KF, Barnes PJ, Kharitonov SA.

Respir Med. 2004 Jul;98(7):651-5.

39.

Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?

Carpagnano GE, Barnes PJ, Francis J, Wilson N, Bush A, Kharitonov SA.

Chest. 2004 Jun;125(6):2005-10.

PMID:
15189915
40.

Exhaled markers of inflammatory lung diseases: ready for routine monitoring?

Kharitonov SA.

Swiss Med Wkly. 2004 Apr 3;134(13-14):175-92. Review.

PMID:
15106031
41.

Repeatability of sodium and chloride in exhaled breath condensates.

Zacharasiewicz A, Wilson N, Lex C, Li A, Kemp M, Donovan J, Hooper J, Kharitonov SA, Bush A.

Pediatr Pulmonol. 2004 Mar;37(3):273-5.

PMID:
14966822
42.

High levels of interleukin-6 in the exhaled breath condensate of patients with COPD.

Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ.

Respir Med. 2003 Dec;97(12):1299-302.

43.
44.

Exhaled breath condensate detects markers of pulmonary inflammation after cardiothoracic surgery.

Moloney ED, Mumby SE, Gajdocsi R, Cranshaw JH, Kharitonov SA, Quinlan GJ, Griffiths MJ.

Am J Respir Crit Care Med. 2004 Jan 1;169(1):64-9. Epub 2003 Oct 9.

PMID:
14551168
45.

Nitric oxide metabolites are not reduced in exhaled breath condensate of patients with primary ciliary dyskinesia.

Csoma Z, Bush A, Wilson NM, Donnelly L, Balint B, Barnes PJ, Kharitonov SA.

Chest. 2003 Aug;124(2):633-8.

PMID:
12907553
46.

Exhaled leukotrienes and prostaglandins in COPD.

Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ.

Thorax. 2003 Jul;58(7):585-8.

47.

Increased inflammatory markers in the exhaled breath condensate of cigarette smokers.

Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ.

Eur Respir J. 2003 Apr;21(4):589-93.

48.

Increased vitronectin and endothelin-1 in the breath condensate of patients with fibrosing lung disease.

Carpagnano GE, Kharitonov SA, Wells AU, Pantelidis P, Du Bois RM, Barnes PJ.

Respiration. 2003 Mar-Apr;70(2):154-60.

PMID:
12740512
49.

A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics.

Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, Barnes PJ.

FASEB J. 2003 Jul;17(10):1298-300. Epub 2003 May 8.

PMID:
12738811
50.

Increased leukotriene B4 and interleukin-6 in exhaled breath condensate in cystic fibrosis.

Carpagnano GE, Barnes PJ, Geddes DM, Hodson ME, Kharitonov SA.

Am J Respir Crit Care Med. 2003 Apr 15;167(8):1109-12.

PMID:
12684249

Supplemental Content

Loading ...
Support Center